NCT06165809 2023-12-29
A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Withdrawn
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
University of Washington
Shanghai Junshi Bioscience Co., Ltd.
M.D. Anderson Cancer Center